Subscribe for Free (RSS + E-mail)

RSS + E-mail

Boston Angel Investors →
Featured▾
- Incubator Guide →
Xconomy National
Xperience
Tech + Life▾
- View More in Xperience ›
Our
Cities▾
Tech
Channels ▾
Meet the
Xconomists ▾
Our
Events ▾

gmaderis

Gail Maderis

Gail Maderis is President & CEO of BayBio, the industry organization representing and supporting Northern California’s life science community. As a former biotech CEO, Ms. Maderis brings deep experience and commitment to supporting the industry through enterprise development, peer-to-peer experience sharing, advocacy and support of education and workforce development. From 2003 to 2009, Ms. Maderis served as President and CEO of Five Prime Therapeutics, Inc., a privately held protein discovery and development company. At FivePrime, she successfully funded the company’s rapid growth through substantial private equity financings and corporate partnerships and took the company’s first novel cancer therapeutic from discovery into clinical trials. Prior to FivePrime, Ms. Maderis held senior executive positions at Genzyme Corporation, including founder and president of Genzyme Molecular Oncology (GZMO). Ms. Maderis practiced management and strategy consulting with Bain & Co. She serves on the boards of BayBio, the Mayor’s Biotech Advisory Council of San Francisco and the HBS Healthcare Initiative. She received a BS in business from the UC Berkeley and an MBA from Harvard Business School.

Recent posts

The Early Stage Innovation Crisis

With more than 850 biotechnology companies, the Bay Area is the oldest, largest and most productive life sciences cluster in the world, employing more than 125,000 people in the region. For... Read more »
It Takes Grassroots Effort to Support Entrepreneurs

Entrepreneurship has fueled economic growth and innovation throughout the Bay Area’s history. We applaud President Barack Obama’s call to action and the White House Startup America program to support entrepreneurs. In... Read more »
Northern California’s Top 5 Biotech Innovation News Stories

The year that was 2010 was another year on the rollercoaster. We had our ups and our downs. But throughout, we continued to be at the forefront of innovation. From mature... Read more »
Prop. 24 Will Hurt California Businesses, Big and Small

Proposition 24, on the November ballot, is all about jobs.

Prop. 24 will cost us as many as 322,000 jobs a year…next year, and for some years to come. Prop. 24... Read more »
How Bay Area Biotech Stacks Up With the Rest of the World

Recently, Newsweek columnist Fareed Zakaria told an audience of biotechnology executives that America’s foothold as the preeminent technology innovator may be slipping.

“Bill Gates is the Britney Spears of China,” Zakaria... Read more »
Three Ways to Create a More Sustainable Future for Biotechnology

1.Encourage tax incentives and policies that would create more investment in biotech. We should create a tax holiday to allow repatriation of offshore profits that are used to fund... Read more »

Page 1 of 1